Keyword: Astellas Pharma


Astellas to Build an Aseptic Drug Products Plant in Ireland

21.09.2023 -

Japanese drugmaker Astellas Pharma plans to build an aseptic drug products facility in County Kerry, Ireland, creating an estimated 350 engineering, science, technology...


Astellas Buys US Bioelectronics Startup

30.10.2020 -

Japanese drugmaker Astellas Pharma has agreed to buy US bioelectronics startup Iota Biosciences. The move follows their R&D agreement signed in August 2019, under which...


Astellas Boosts Eye Disease Platform with Quethera

16.08.2018 - Japan’s Astellas Pharma has acquired Cambridge, UK-based Quethera, a gene therapy company focused on developing novel treatments for eye disease, such as glaucoma. The acquisition...


ABPI Extends Suspension of Astellas UK

28.06.2017 - The Association of the British Pharmaceutical Industry (ABPI) has suspended Astellas UK’s membership for a further 12 months from Jun. 24 because of several serious breaches of its...

Chemistry & Life Sciences

2015 Facility of the Year Awards Category Winners

08.06.2015 - On June 2, The International Society for Pharmaceutical Engineering (ISPE) formally appreciated its 2015 Facility of the Year Awards (FOYA) category winners at a banquet in...


Qiagen and Astellas Pharma to Develop Companion Diagnostics

03.11.2014 - Dutch genetic testing specialist Qiagen has signed a master collaboration agreement with Astellas Pharma, a Japanese R&D-driven global pharmaceutical company, to develop and...


FDA Warns Of Heart Risks with Astellas Stress Test Chemicals

21.11.2013 - The U.S. Food and Drug Administration warned physicians on Wednesday that two chemicals used to conduct cardiovascular stress tests can cause heart attacks and death, and it...


China Launches Pharma Crackdown

18.07.2013 - China announced a nationwide crackdown on the sale of illegal medicine on Wednesday and said it would tighten industry regulation, piling pressure on a sector already reeling from...